LAS VEGAS, Aug 14, 2006 (BUSINESS WIRE) -- Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR), a leading developer and marketer of powdered nutritional ingredients, announced the introduction of a near odorless and tasteless DHA oil and companion dry powder.
"The development of our near odorless DHA oil and powder is a direct result of the increasing market demand for the cognitive and cardiovascular health benefits associated with DHA (Docosahexaenoic Acid)," noted NPRI President Godfrey Yew.
Small clinical studies have shown DHA increases HDL-cholesterol, the "good" cholesterol known to protect against heart disease, while reducing fats known as triglycerides. Among children, DHA has been shown to be helpful in the development of a healthy nervous system, cognitive development and visual ability.
According to the company, food marketers can now incorporate the near odorless DHA oil directly into salad dressings, dairy products, fruit drinks, confectionaries and like products, adding fortification along with nutrition. "With our near odorless DHA oil, food companies no longer need to worry about micro-encapsulating a fish oil to hide the typical fishy smell and taste of most DHA oils," stated Yew. "Likewise, the dry powder form can add DHA fortification into breads, cakes, cookies and other dry mix products, protein and snack bars, snack foods, powdered formula and drink mixes for infants and children, as well as in nutraceutical formulas," he added.
The powdered DHA uses NPRI's patent-pending O2P oil-to-powder technology, a proprietary process that converts oils to powders at room temperature, under normal atmosphere in an oxygen-free environment. Powders are available in a free-flowing food grade for dry mix, beverage and other food applications and/or direct-compressible powder for capsules and tableting.
Nutri Pharmaceuticals Research Inc. ( www.o2pus.com) provides a wide range of powdered oils for functional food, food supplement, cosmetic, pet food and animal feed applications. The company is one of a select few to be awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patented O2P(TM) Powderization Process.
At the heart of its oil powders is the O2P Oil-to-Powder technology. This patent-pending process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P does not rely on traditional techniques that utilize extremes in heat or cold, or micro-encapsulation technology. This facilitates food marketing and supplement producers' ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues. The company currently offers more than 50 shelf-stable powders. The company can also apply O2P technology to a third-party's oil, paste or gel through an arrangement called tolling. Based in Las Vegas, the company has representative sales offices near Chicago, Amsterdam, Guatemala City and Bangkok. Nutri Pharmaceuticals Research Inc. shares are currently traded in the United States on the "Pinksheets" under the symbol NRPR.PK.
The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements.